119 related articles for article (PubMed ID: 96459)
1. Effects of perphenazine enanthate injections on prolactin levels in plasma from schizophrenic women and men.
Lindholm H; Gullberg B; Ohman A; Sedvall G
Psychopharmacology (Berl); 1978 Apr; 57(1):1-4. PubMed ID: 96459
[TBL] [Abstract][Full Text] [Related]
2. Perphenazine decanoate in sesame oil vs. perphenazine enanthate in sesame oil: a comparative study of pharmacokinetic properties and some clinical implications.
Knudsen P; Hansen LB; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():11-4. PubMed ID: 3865500
[TBL] [Abstract][Full Text] [Related]
3. Plasma fluphenazine and prolactin levels in schizophrenic patients during treatment with low and high doses of fluphenazine enanthate.
Wiles D; Franklin M; Dencker SJ; Johansson R; Lundin L; Malm U
Psychopharmacology (Berl); 1980; 71(2):131-6. PubMed ID: 6777812
[TBL] [Abstract][Full Text] [Related]
4. Perphenazine decanoate vs. perphenazine enanthate: efficacy and side effects in a 6 week double-blind, comparative study of 50 drug monitored psychotic patients.
Knudsen P; Hansen LB; Auken G; Waehrens J; Højholdt K; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():15-28. PubMed ID: 3907278
[TBL] [Abstract][Full Text] [Related]
5. Depot perphenazine decanoate and enanthate for schizophrenia.
Quraishi S; David A
Cochrane Database Syst Rev; 2000; (2):CD001717. PubMed ID: 10796445
[TBL] [Abstract][Full Text] [Related]
6. Prolactin and blood pressure responses to perphenazine in human subjects: comparison of the oral and intramuscular routes.
Musey VC; Preedy JR; Musey PI; Blank MS; Brogan DR; Bain RP; Collins DC
Am J Med Sci; 1986 Jun; 291(6):380-5. PubMed ID: 3717195
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic implications of different oil vehicles used in depot neuroleptic treatment.
Knudsen P; Hansen LB; Larsen NE
Acta Psychiatr Scand Suppl; 1985; 322():7-10. PubMed ID: 3865501
[TBL] [Abstract][Full Text] [Related]
8. A preliminary study of sex-related differences in prolactin responses to dopamine blockade and insulin hypoglycemia and in penfluridol plasma levels in schizophrenic patients.
Nathan RS; Sachar EJ; Ostrow L; Asnis GM; Halbreich U; Halpern F; Renzi NL; Slotnick V
Psychopharmacology (Berl); 1983; 80(1):46-9. PubMed ID: 6408670
[TBL] [Abstract][Full Text] [Related]
9. Prolactin and growth hormone levels in different inbred strains of mice: patterns in association with estrous cycle, time of day, and perphenazine stimulation.
Sinha YN; Salocks CB; Vanderlaan WP
Endocrinology; 1975 Nov; 97(5):1112-22. PubMed ID: 1237395
[TBL] [Abstract][Full Text] [Related]
10. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge.
Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M
Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731
[TBL] [Abstract][Full Text] [Related]
11. Estrogen in high doses inhibits perphenazine-induced prolactin release.
Sinha YN; Gilligan TA
Endocrinology; 1982 Jan; 110(1):126-30. PubMed ID: 7053978
[TBL] [Abstract][Full Text] [Related]
12. Molecular size variants of prolactin and growth hormone in mouse serum: strain differences and alterations of concentrations by physiological and pharmacological stimuli.
Sinha YN
Endocrinology; 1980 Dec; 107(6):1959-69. PubMed ID: 7428700
[TBL] [Abstract][Full Text] [Related]
13. Alterations in oxidative stress markers and its correlation with clinical findings in schizophrenic patients consuming perphenazine, clozapine and risperidone.
Hendouei N; Farnia S; Mohseni F; Salehi A; Bagheri M; Shadfar F; Barzegar F; Hoseini SD; Charati JY; Shaki F
Biomed Pharmacother; 2018 Jul; 103():965-972. PubMed ID: 29710513
[TBL] [Abstract][Full Text] [Related]
14. The relationship between perphenazine plasma levels and clinical response in acute schizophrenia.
Omérov M; Wistedt B; Bolvig-Hansen L; Larsen NE
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):159-66. PubMed ID: 2664884
[TBL] [Abstract][Full Text] [Related]
15. The cimetidine-induced increase in prolactin secretion in schizophrenia: effect of clozapine.
Meltzer HY; Maes M; Lee MA
Psychopharmacology (Berl); 1993; 112(1 Suppl):S95-104. PubMed ID: 7831446
[TBL] [Abstract][Full Text] [Related]
16. Prolactin stimulation test with perphenazine: an evaluation of plasma prolactin levels and pituitary secretory activity in the rat.
van der Gugten AA; Sahuleka PC; van Galen GH
J Endocrinol; 1976 Mar; 68(3):355-68. PubMed ID: 3617
[TBL] [Abstract][Full Text] [Related]
17. The effect of thioridazine on prolactin levels in acutely schizophrenic patients: challenge-dose and steady-state levels.
Johnson GF; Hunt GE
Aust N Z J Psychiatry; 1980 Jun; 14(2):127-31. PubMed ID: 6932868
[TBL] [Abstract][Full Text] [Related]
18. Multiphasic prolactin release and mammary development in virgin rats after prolonged treatment with perphenazine or perphenazine sulphoxide.
Shani J; Givant Y; Goldhaber G; Sulman FG
J Endocrinol; 1976 Aug; 70(2):311-2. PubMed ID: 965888
[No Abstract] [Full Text] [Related]
19. BL-1020: a novel antipsychotic drug with GABAergic activity and low catalepsy, is efficacious in a rat model of schizophrenia.
Geffen Y; Nudelman A; Gil-Ad I; Rephaeli A; Huang M; Savitsky K; Klapper L; Winkler I; Meltzer HY; Weizman A
Eur Neuropsychopharmacol; 2009 Jan; 19(1):1-13. PubMed ID: 18757185
[TBL] [Abstract][Full Text] [Related]
20. Differences in plasma prolactin levels in patients with schizophrenia treated on monotherapy with five second-generation antipsychotics.
Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Tsuneyama N; Saito M; Someya T
Schizophr Res; 2013 Apr; 145(1-3):116-9. PubMed ID: 23375624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
